second generation HDAC inhibitor (Errant Gene Therapeutics)

N/A

Report date: 2025/03/20 15:15:54
NME

Base Information

Drug Namesecond generation HDAC inhibitor (Errant Gene Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsLung Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSan Rocco Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesSan Rocco Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsLung Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A